UniProt ID | BZW2_HUMAN | |
---|---|---|
UniProt AC | Q9Y6E2 | |
Protein Name | Basic leucine zipper and W2 domain-containing protein 2 | |
Gene Name | BZW2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 419 | |
Subcellular Localization | ||
Protein Description | May be involved in neuronal differentiation.. | |
Protein Sequence | MNKHQKPVLTGQRFKTRKRDEKEKFEPTVFRDTLVQGLNEAGDDLEAVAKFLDSTGSRLDYRRYADTLFDILVAGSMLAPGGTRIDDGDKTKMTNHCVFSANEDHETIRNYAQVFNKLIRRYKYLEKAFEDEMKKLLLFLKAFSETEQTKLAMLSGILLGNGTLPATILTSLFTDSLVKEGIAASFAVKLFKAWMAEKDANSVTSSLRKANLDKRLLELFPVNRQSVDHFAKYFTDAGLKELSDFLRVQQSLGTRKELQKELQERLSQECPIKEVVLYVKEEMKRNDLPETAVIGLLWTCIMNAVEWNKKEELVAEQALKHLKQYAPLLAVFSSQGQSELILLQKVQEYCYDNIHFMKAFQKIVVLFYKADVLSEEAILKWYKEAHVAKGKSVFLDQMKKFVEWLQNAEEESESEGEEN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Ubiquitination | --MNKHQKPVLTGQR --CCCCCCCCCCCCC | 36.49 | - | |
6 | Acetylation | --MNKHQKPVLTGQR --CCCCCCCCCCCCC | 36.49 | 26822725 | |
10 | Phosphorylation | KHQKPVLTGQRFKTR CCCCCCCCCCCCCCC | 31.35 | 29496963 | |
24 | Ubiquitination | RKRDEKEKFEPTVFR CCCCHHHCCCCCCHH | 67.12 | - | |
24 | Acetylation | RKRDEKEKFEPTVFR CCCCHHHCCCCCCHH | 67.12 | 27452117 | |
33 | Phosphorylation | EPTVFRDTLVQGLNE CCCCHHHHHHHHHHH | 25.27 | 21712546 | |
55 | O-linked_Glycosylation | VAKFLDSTGSRLDYR HHHHHHCCCCCCCHH | 38.55 | 28510447 | |
57 | Phosphorylation | KFLDSTGSRLDYRRY HHHHCCCCCCCHHHH | 29.74 | - | |
57 | O-linked_Glycosylation | KFLDSTGSRLDYRRY HHHHCCCCCCCHHHH | 29.74 | 28510447 | |
93 | Sulfoxidation | DDGDKTKMTNHCVFS CCCCCCEECCCEEEE | 5.70 | 21406390 | |
94 | Phosphorylation | DGDKTKMTNHCVFSA CCCCCEECCCEEEEC | 24.30 | 26126808 | |
117 | Ubiquitination | NYAQVFNKLIRRYKY HHHHHHHHHHHHHHH | 33.55 | 21890473 | |
117 | Ubiquitination | NYAQVFNKLIRRYKY HHHHHHHHHHHHHHH | 33.55 | 21890473 | |
117 | Acetylation | NYAQVFNKLIRRYKY HHHHHHHHHHHHHHH | 33.55 | 19608861 | |
117 | Ubiquitination | NYAQVFNKLIRRYKY HHHHHHHHHHHHHHH | 33.55 | 21906983 | |
122 | Phosphorylation | FNKLIRRYKYLEKAF HHHHHHHHHHHHHHC | 8.30 | 26657352 | |
123 | Acetylation | NKLIRRYKYLEKAFE HHHHHHHHHHHHHCH | 41.36 | 26051181 | |
124 | Phosphorylation | KLIRRYKYLEKAFED HHHHHHHHHHHHCHH | 15.91 | 26657352 | |
134 | Acetylation | KAFEDEMKKLLLFLK HHCHHHHHHHHHHHH | 37.92 | 27452117 | |
135 | Ubiquitination | AFEDEMKKLLLFLKA HCHHHHHHHHHHHHH | 42.95 | 21890473 | |
135 | Ubiquitination | AFEDEMKKLLLFLKA HCHHHHHHHHHHHHH | 42.95 | 21890473 | |
135 | Ubiquitination | AFEDEMKKLLLFLKA HCHHHHHHHHHHHHH | 42.95 | 21890473 | |
144 | Phosphorylation | LLFLKAFSETEQTKL HHHHHHCCCCHHHHH | 48.76 | 28102081 | |
146 | Phosphorylation | FLKAFSETEQTKLAM HHHHCCCCHHHHHHH | 31.99 | 28102081 | |
149 | Phosphorylation | AFSETEQTKLAMLSG HCCCCHHHHHHHHHC | 23.07 | 28102081 | |
185 | Phosphorylation | VKEGIAASFAVKLFK HHHHHHHHHHHHHHH | 12.52 | 25954137 | |
202 | Phosphorylation | MAEKDANSVTSSLRK HHHCCHHHHHHHHHH | 28.61 | 25159151 | |
204 | Phosphorylation | EKDANSVTSSLRKAN HCCHHHHHHHHHHCC | 16.66 | 21712546 | |
205 | Phosphorylation | KDANSVTSSLRKANL CCHHHHHHHHHHCCC | 25.81 | 25627689 | |
206 | Phosphorylation | DANSVTSSLRKANLD CHHHHHHHHHHCCCC | 23.87 | 25627689 | |
226 | Phosphorylation | LFPVNRQSVDHFAKY HCCCCHHHHHHHHHH | 26.69 | 27251275 | |
232 | Ubiquitination | QSVDHFAKYFTDAGL HHHHHHHHHHHHHCH | 39.70 | 21890473 | |
232 | Ubiquitination | QSVDHFAKYFTDAGL HHHHHHHHHHHHHCH | 39.70 | 21890473 | |
240 | Ubiquitination | YFTDAGLKELSDFLR HHHHHCHHHHHHHHH | 56.54 | 21890473 | |
243 | Phosphorylation | DAGLKELSDFLRVQQ HHCHHHHHHHHHHHH | 27.66 | - | |
260 | Acetylation | GTRKELQKELQERLS CCHHHHHHHHHHHHH | 73.37 | 27452117 | |
260 | Ubiquitination | GTRKELQKELQERLS CCHHHHHHHHHHHHH | 73.37 | - | |
267 | Phosphorylation | KELQERLSQECPIKE HHHHHHHHCCCCHHH | 30.10 | - | |
310 | Ubiquitination | NAVEWNKKEELVAEQ HHHHCCHHHHHHHHH | 53.89 | - | |
320 | Ubiquitination | LVAEQALKHLKQYAP HHHHHHHHHHHHHHH | 50.32 | 21890473 | |
320 | Ubiquitination | LVAEQALKHLKQYAP HHHHHHHHHHHHHHH | 50.32 | 21890473 | |
358 | Ubiquitination | YDNIHFMKAFQKIVV HHCHHHHHHHHHHHH | 45.14 | 21890473 | |
358 | Ubiquitination | YDNIHFMKAFQKIVV HHCHHHHHHHHHHHH | 45.14 | 21890473 | |
383 | Ubiquitination | EAILKWYKEAHVAKG HHHHHHHHHHHHHCC | 47.51 | - | |
391 | Acetylation | EAHVAKGKSVFLDQM HHHHHCCCCHHHHHH | 42.62 | 27452117 | |
391 | Malonylation | EAHVAKGKSVFLDQM HHHHHCCCCHHHHHH | 42.62 | 26320211 | |
392 | Phosphorylation | AHVAKGKSVFLDQMK HHHHCCCCHHHHHHH | 27.11 | 28348404 | |
412 | Phosphorylation | LQNAEEESESEGEEN HHHHHHHHHHCCCCC | 50.10 | 20201521 | |
414 | Phosphorylation | NAEEESESEGEEN-- HHHHHHHHCCCCC-- | 61.25 | 20201521 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BZW2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BZW2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BZW2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ABHEA_HUMAN | ABHD14A | physical | 22863883 | |
PSF3_HUMAN | GINS3 | physical | 22863883 | |
PA1B2_HUMAN | PAFAH1B2 | physical | 22863883 | |
EIF2A_HUMAN | EIF2A | physical | 21745818 | |
EI2BA_HUMAN | EIF2B1 | physical | 21745818 | |
EIF3A_HUMAN | EIF3A | physical | 21745818 | |
IF2G_YEAST | GCD11 | physical | 21745818 | |
IF2A_YEAST | SUI2 | physical | 21745818 | |
EIF3B_YEAST | PRT1 | physical | 21745818 | |
EI2BE_YEAST | GCD6 | genetic | 21745818 | |
MUL1_HUMAN | MUL1 | physical | 28514442 | |
EXOG_HUMAN | EXOG | physical | 28514442 | |
5NT3A_HUMAN | NT5C3A | physical | 28514442 | |
CANT1_HUMAN | CANT1 | physical | 28514442 | |
ENDD1_HUMAN | ENDOD1 | physical | 28514442 | |
TMM43_HUMAN | TMEM43 | physical | 28514442 | |
ZFPL1_HUMAN | ZFPL1 | physical | 28514442 | |
SCPDL_HUMAN | SCCPDH | physical | 28514442 | |
MRS2_HUMAN | MRS2 | physical | 28514442 | |
MAVS_HUMAN | MAVS | physical | 28514442 | |
OMA1_HUMAN | OMA1 | physical | 28514442 | |
TV23C_HUMAN | TVP23C | physical | 28514442 | |
NXT1_HUMAN | NXT1 | physical | 28514442 | |
RRAS_HUMAN | RRAS | physical | 28514442 | |
RASN_HUMAN | NRAS | physical | 28514442 | |
S27A2_HUMAN | SLC27A2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-414, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-414, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-414, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-414, ANDMASS SPECTROMETRY. |